Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2020
Total Assets: $11.75B
Liabilities Breakdown FY2020
Total Liabilities: $3.07B
Asset Breakdown
Total Assets: $11.75B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.99B | 51.0% |
| Accounts Receivable | $885.4M | 7.5% |
| Inventory | $280.8M | 2.4% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $1.00B | 8.5% |
| Intangible Assets | $400.0M | 3.4% |
| Other Assets | $3.20B | 27.2% |
Liabilities Breakdown
Total Liabilities: $3.07B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $155.1M | 5.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.91B | 94.9% |